1. Home
  2. Stocks
  3. Tatva Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Tatva Chintan Pharma Chem Share Price Tatva Chintan Pharma Chem

    Small Cap
    ₹1,254.9
    +2.05 (0.16%)
    25 April, 2024 13:15 BSE: 543321 NSE: TATVAISIN: INE0GK401011

    Start SIP in Tatva Chintan Pharma Chem

    Start SIP

    Tatva Chintan Pharma Chem Performance

    Day Range

    • Low 1,235
    • High 1,267
    ₹ 1,254

    52 Week Range

    • Low 1,061
    • High 1,888
    ₹ 1,254
    • Open Price1,250
    • Previous Close1,253
    • Volume7444

    Tatva Chintan Pharma Chem Share Price

    • Over 1 Month +8.16%
    • Over 3 Month -7.46%
    • Over 6 Month -14.6%
    • Over 1 Year -23.09%

    Tatva Chintan Pharma Chem Key Statistics

    P/E Ratio 77.9
    PEG Ratio -4.3
    Market Cap Cr 2,936
    Price to Book Ratio 5.7
    EPS 18.8
    Dividend 0.2
    Relative Strength Index 55.8
    Money Flow Index 75.5
    MACD Signal 4.69
    Average True Range 39.73
    Tatva Chintan Pharma Chem Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 8693106119
    Operating Expenses Qtr Cr 747286104
    Operating Profit Qtr Cr 12212015
    Depreciation Qtr Cr 7763
    Interest Qtr Cr 0333
    Tax Qtr Cr 243-9
    Net Profit Qtr Cr 58816
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 409
    Operating Expenses Annual Cr 348
    Operating Profit Annual in Cr 55
    Depreciation Cr 10
    Interest Annual Cr 8
    Tax Annual Cr -2
    Net Profit Annual Cr 40
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 24
    Cash from Investing Activity Annual Cr -101
    Cash from Financing Annual Activity Cr 38
    Net Cash Flow Annual Cr -40
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 505
    Fixed Assets Annual Cr 427
    Total Non Current Assets Annual Cr 443
    Total Current Assets Annual Cr 311
    Total Assets Annual Cr 755
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 228
    ROE Annual % 8
    ROCE Annual % 10
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 15
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 8497114125
    Operating Expenses Qtr Cr 737693108
    Operating Profit Qtr Cr 11202116
    Depreciation Qtr Cr 7763
    Interest Qtr Cr 0333
    Tax Qtr Cr 234-9
    Net Profit Qtr Cr 381017
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 429
    Operating Expenses Annual Cr 363
    Operating Profit Annual in Cr 61
    Depreciation Cr 10
    Interest Annual Cr 8
    Tax Annual Cr -1
    Net Profit Annual Cr 45
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 28
    Cash from Investing Activity Annual Cr -101
    Cash from Financing Annual Activity Cr 38
    Net Cash Flow Annual Cr -36
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 515
    Fixed Assets Annual Cr 427
    Total Non Current Assets Annual Cr 443
    Total Current Assets Annual Cr 314
    Total Assets Annual Cr 756
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 232
    ROE Annual % 9
    ROCE Annual % 11
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 16
    Sign Up to Know More
    Invest in Tatva Chintan Pharma Chem

    Tatva Chintan Pharma Chem Technicals

    EMA & SMA

    Current Price
    ₹1,254.9
    +2.05 (0.16%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹1,225.69
    • 50 Day
    • ₹1,249.00
    • 100 Day
    • ₹1,327.76
    • 200 Day
    • ₹1,467.15
    • 20 Day
    • ₹1,209.72
    • 50 Day
    • ₹1,217.42
    • 100 Day
    • ₹1,359.22
    • 200 Day
    • ₹1,486.97

    Tatva Chintan Pharma Chem Resistance and Support

    PIVOT
    ₹1,251.67
    Resistance
    First Resistance 1,271.28
    Second Resistance 1,289.72
    Third Resistance 1,309.33
    RSI 55.80
    MFI 75.50
    MACD Single Line 4.69
    MACD 8.74
    Support
    First Resistance 1,233.23
    Second Resistance 1,213.62
    Third Resistance 1,195.18

    Tatva Chintan Pharma Chem Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 12,698 674,264 53.1
    Week 13,499 630,278 46.69
    1 Month 40,428 2,032,321 50.27
    6 Month 32,446 1,835,468 56.57

    Tatva Chintan Pharma Chem Result Highlights

    Tatva Chintan Pharma Chem Synopsis

    NSE-Chemicals-Basic

    Tatva Chintan Pharm is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 403.04 Cr. and Equity Capital is Rs. 22.17 Cr. for the Year ended 31/03/2023. Tatva Chintan Pharma Chem Ltd. is a Public Limited Listed company incorporated on 12/06/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ1996PLC029894 and registration number is 029894.
    Market Cap 2,942
    Sales 404
    Shares in Float 0.65
    No of funds 35
    Yield 0.16
    Book Value 5.5
    U/D Vol ratio 0.9
    LTDebt / Equity 1
    Alpha -0.16
    Beta 0.53

    Tatva Chintan Pharma Chem

    Owner NameMar-24Dec-23Sep-23Aug-23
    Promoters 72.02%72.02%72.02%75.02%
    Mutual Funds 12.84%13.05%13.54%13.57%
    Insurance Companies 0.11%0.11%
    Foreign Portfolio Investors 3.65%4.21%4.4%4.13%
    Individual Investors 10.49%9.39%8.72%6.23%
    Others 1%1.33%1.21%0.94%

    Tatva Chintan Pharma Chem Management

    Name Designation
    Mr. Chintan Nitinkumar Shah Chairman & Managing Director
    Mr. Ajaykumar Mansukhlal Patel Whole Time Director
    Mr. Shekhar Rasiklal Somani Whole Time Director
    Dr. Manher Chimanlal Desai Independent Director
    Mr. Subhash Ambubhai Patel Independent Director
    Dr. Avani Rajesh Umatt Independent Director

    Tatva Chintan Pharma Chem Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Tatva Chintan Pharma Chem Corporate Action

    Date Purpose Remarks
    2024-05-03 Audited Results & Final Dividend
    2024-01-20 Quarterly Results
    2023-11-02 Quarterly Results
    2023-08-04 Quarterly Results
    2023-07-11 Preferential issue of shares
    Date Purpose Remarks
    2022-09-09 FINAL Rs.2.00 per share(20%)Final Dividend

    Tatva Chintan Pharma Chem MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 45,749
    SBI Magnum Midcap Fund Regular Growth 16,856
    Nippon India ELSS Tax Saver Fund Growth 14,322
    Mirae Asset Aggressive Hybrid Fund -Regular Plan-Growth 8,401
    ICICI Prudential Smallcap Fund Growth 7,173

    Tatva Chintan Pharma Chem FAQs

    What is Share Price of Tatva Chintan Pharma Chem ?

    Tatva Chintan Pharma Chem share price is ₹1,254 As on 25 April, 2024 | 13:01

    What is the Market Cap of Tatva Chintan Pharma Chem ?

    The Market Cap of Tatva Chintan Pharma Chem is ₹2935.5 Cr As on 25 April, 2024 | 13:01

    What is the P/E ratio of Tatva Chintan Pharma Chem ?

    The P/E ratio of Tatva Chintan Pharma Chem is 77.9 As on 25 April, 2024 | 13:01

    What is the PB ratio of Tatva Chintan Pharma Chem ?

    The PB ratio of Tatva Chintan Pharma Chem is 5.7 As on 25 April, 2024 | 13:01

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.